insights_auto
Outlook: 80.0% bullish·0.0% bearish
Go to analysischevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$782.04
arrow_downward
-1.10%(-8.70) 1D
$782.04
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$792.59
High
$800.00
Low
$780.83
Mkt. cap
80.51B
Avg. vol.
719.60K
Volume
489.58K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.33
52-wk high
$859.34
52-wk low
$572.75
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
Open
$792.59
High
$800.00
Low
$780.83
Mkt. cap
80.51B
Avg. vol.
719.60K
Volume
489.58K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.33
52-wk high
$859.34
52-wk low
$572.75
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
News Corp
·
5 hours ago
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
MarketBeat
·
8 hours ago
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by BDF Gestion
GuruFocus
·
8 hours ago
REGN Maintained by Piper Sandler -- Price Target Raised to $865
Trefis
·
8 hours ago
How Much Upside Is Left In Regeneron Stock?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com